LinkedIn post Isologic goes electric
🔌Isologic Goes Electric!
We are excited to announce the expansion of our electric fleet with the addition of the Mercedes-Benz eCitan. This compact and sustainable vehicle boasts a range of approximately 280km and can be rapidly charged from 20% to 80% ursing fast-charging stations.
Our commitment to electric mobility is driven by our collaboration with Radboud Translational Medicine B.V., where we transport medical isotopes daily to healthcare facilities both domestically and internationally. Furthermore, many of our clients are increasingly seeking sustainable logistics solutions. With the implementation of zero-emission zones in cities such as Nijmegen, and the expectation that more cities will follow this example, this is a significant step forward.
At Isologic, delivery reliability is paramount: it is crucial that hospitals receive the necessary medical sources on time for patient treatment. The Mercedes-Benz eCitan supports us in this mission with its dependable performance and swift charging capabilities.
A notable feature of this eCitan is its specialized software that optimizes temperature settings for efficient charging. We will now rigorously test the performance and reliability of this electric van, as we previously did with an electric FIAT Doblo. Interested in the results? Please contact us: https://lnkd.in/et8ny4EK
#Isologic hashtag#ElectricDriving hashtag#Sustainability hashtag#Logistics hashtag#Healthcare hashtag#ZeroEmission

Other news

LinkedIn post ESRR2024
📢 Important update on EU #GMP Annex 1 at #ESRR2024! The revised EU GMP Annex 1, effecti...

1st production QuiremSpheres
On May 21st, the first patient dosis of QuiremSpheres was processed at RTM and then shipped to the s...

First liver cancer patient treated with microspheres irradiated in TU Delft
Radboud Translational Medicine will perform the dispensing of below product. The production and dis...

GMP-certificate received
Today we received our GMP-certificate!The results of the inspection were excellent and no shortcomin...
Interested in a collaboration?
Contact us to discuss the possibilities.